Sequent - Cup and Handle formation - Best above 158

16 sie 2024

Sequent Scientific had Superb set of Results (₹ in Mlns)

YOY (qtr)👍

REV⬆️₹3902 vs ₹3332
PBT⬆️₹120 vs ₹-556
PAT⬆️₹90 vs ₹-346
EPS⬆️0.26 vs -1.4

QOQ (qtr)👍

REV⬆️₹3902 vs ₹3612
PBT⬆️₹120 vs ₹26
PAT⬆️₹90 vs ₹12.7
EPS⬆️0.26 vs -0.04



The Stock is forming Cup & Handle Pattern with turaround from this quarter.
The stock can be added above 158 for Targets of 220/280/340

Strict stoploss of 132.

Disclaimer : Educational Content. Please do your own research.

20 sie 2024

Zlecenie aktywne

News

SeQuent Scientific: Gets prequalification (PQ) approval from WHO for the Albendazole API. This is in partnership with Mepro Pharma, who has successfully developed and commercialised the Albendazole Chewable formulation from its WHO PQ approved plant, using its API. The chewable formulation is the first of its kind approved by the WHO PQ.